ArticleJournal of inflammation (London, England)2023

SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia.

Bianca Vezzani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.